Native T1 mapping in transthyretin amyloidosis.

Native T1 mapping in transthyretin amyloidosis.

Pokaži ostale verzije (1)

The aims of the study were to explore the ability of native myocardial T1 mapping by cardiac magnetic resonance to: 1) detect cardiac involvement in patients with transthyretin amyloidosis (ATTR amyloidosis); 2) track the cardiac amyloid burden; and 3) detect early disease.ATTR amyloidosis is an und...

Bibliografski detalji
Glavni autori:	Fontana, M, Banypersad, S, Treibel, T, Maestrini, V, Sado, D, White, S, Pica, S, Castelletti, S, Piechnik, S, Robson, M, Gilbertson, J, Rowczenio, D, Hutt, D, Lachmann, H, Wechalekar, A, Whelan, C, Gillmore, J, Hawkins, P, Moon, J
Format:	Journal article
Jezik:	English
Izdano:	2014

Slični predmeti

Native T1 mapping in transthyretin amyloidosis
od: Fontana, M, i dr.
Izdano: (2014)

Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis
od: Dungu Jason, i dr.
Izdano: (2012-02-01)

Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis.
od: Karamitsos, T, i dr.
Izdano: (2012)

Multiorgan Dysfunction and Associated Prognosis in Transthyretin Cardiac Amyloidosis
od: Adam Ioannou, i dr.
Izdano: (2024-02-01)

Abnormal N-terminal fragment of brain natriuretic peptide in patients with light chain amyloidosis without cardiac involvement at presentation is a risk factor for development of cardiac amyloidosis
od: Ashutosh D. Wechalekar, i dr.
Izdano: (2011-07-01)

Efficacy of bortezomib in systemic AL amyloidosis with relapsed/refractory clonal disease
od: Ashutosh D. Wechalekar, i dr.
Izdano: (2008-02-01)

Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis
od: Karamitsos, T, i dr.
Izdano: (2013)

Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.
od: Karamitsos, T, i dr.
Izdano: (2013)

The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis
od: Tamer Rezk, i dr.
Izdano: (2019-07-01)

A prospective study of nutritional status in immunoglobulin light chain amyloidosis
od: Prayman T. Sattianayagam, i dr.
Izdano: (2013-01-01)

Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis
od: Karamitsos Theodoros, i dr.
Izdano: (2012-02-01)

Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria
od: Faye A. Sharpley, i dr.
Izdano: (2020-05-01)

Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis.
od: Richards, D, i dr.
Izdano: (2018)

Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping.
od: Sado, D, i dr.
Izdano: (2013)

Ethnicity in systemic AL amyloidosis may impact risk stratification
od: Jahanzaib Khwaja, i dr.
Izdano: (2025-01-01)

T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique.
od: White, S, i dr.
Izdano: (2013)

T1 mapping for myocardial extracellular volume measurement by CMR: Bolus only versus primed infusion technique
od: White, S, i dr.
Izdano: (2013)

Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib
od: Sriram Ravichandran, i dr.
Izdano: (2021-06-01)

Management of transthyretin amyloidosis
od: Adalgisa Condoluci, i dr.
Izdano: (2021-10-01)

Cardiac transplantation in transthyretin amyloid cardiomyopathy: Outcomes from three decades of tertiary center experience
od: Yousuf Razvi, i dr.
Izdano: (2023-01-01)

Hereditary transthyretin amyloidosis
od: T. A. Adyan, i dr.
Izdano: (2020-01-01)

Native T1 lowering in iron overload and Anderson Fabry disease; a novel and early marker of disease
od: Sado Daniel, i dr.
Izdano: (2013-01-01)

Multiorgan ECV as measured by EQ-MRI in systemic amyloidosis
od: Banypersad Sanjay M, i dr.
Izdano: (2013-01-01)

Rapid hematologic responses improve outcomes in patients with very advanced (stage IIIb) cardiac immunoglobulin light chain amyloidosis
od: Richa Manwani, i dr.
Izdano: (2018-04-01)

Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR.
od: Fontana, M, i dr.
Izdano: (2012)

Transthyretin Cardiac Amyloidosis: Underrecognized in the Underrepresented
od: Douglas J. Leedy, i dr.
Izdano: (2023-08-01)

Erratum to: Management of transthyretin amyloidosis
od: Swiss Medical Weekly
Izdano: (2021-11-01)

Renal Amyloidosis Associated With 5 Novel Variants in the Fibrinogen A Alpha Chain Protein
od: Dorota Rowczenio, i dr.
Izdano: (2017-05-01)

World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
od: Dulce Brito (Chair), i dr.
Izdano: (2023-10-01)

Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner
od: Morie Gertz, i dr.
Izdano: (2020-09-01)

Coexistence of Light Chain and Transthyretin Cardiac Amyloidosis
od: Abhishek Gami, MD, i dr.
Izdano: (2024-04-01)

Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosis
od: Sajitha Sachchithanantham, i dr.
Izdano: (2015-11-01)

Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis
od: Hiroki Yamaguchi, i dr.
Izdano: (2022-03-01)

Specific therapeutic options for transthyretin amyloidosis
od: Zoltán Pozsonyi
Izdano: (2024-12-01)

Clinical case of hereditary transthyretin amyloidosis
od: N. Spasova, i dr.
Izdano: (2024-12-01)

Diagnostic algorithm in transthyretin amyloidosis with cardiomyopathy
od: Mariana Gospodinova, i dr.
Izdano: (2020-07-01)

A review of transthyretin cardiac amyloidosis
od: Jhawar Nikita, i dr.
Izdano: (2023-03-01)

Transthyretin Amyloidosis Therapies: Guiding the Future
od: Alejandra González-Duarte
Izdano: (2021-01-01)

Modulation of the Mechanisms Driving Transthyretin Amyloidosis
od: Filipa Bezerra, i dr.
Izdano: (2020-12-01)

Disease-Modifying Therapy for Transthyretin Amyloidosis
od: Nowell M. Fine, MD, SM
Izdano: (2020-11-01)